SCHEMBL7989488

SCHEMBL7989488

COc1ccccc1C(CNCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(Cc2ccc3c(c2)OCO3)CC1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 7/20 0.49
MCHR1 Q99705 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
LMNA P02545 4/20 0.48
HTT P42858 1/20 0.48
APOBEC3A P31941 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ATM Q13315 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7925958 0.87 TACR1 (0.56) TACR1ALDH1A1KMT2A
SCHEMBL7932667 0.86 LMNA (0.47) TACR1MCHR1SMN1; SMN2LMNAALDH1A1
SCHEMBL8919854 0.82 SMN1; SMN2 (0.52) MCHR1SMN1; SMN2LMNAHTTAPOBEC3A
SCHEMBL7932658 0.82 TACR1 (0.56) TACR1
SCHEMBL7938507 0.81 TACR1 (0.60) TACR1
SCHEMBL7936460 0.81 TACR1 (0.60) TACR1
SCHEMBL7925947 0.81 TACR1 (0.58) TACR1
SCHEMBL6479126 0.80 TACR1 (0.54) TACR1
SCHEMBL7934639 0.80 TACR1 (0.58) TACR1
SCHEMBL7934948 0.79 TACR1 (0.59) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191135-B1 Neurokinin antagonists BOEHRINGER INGELHEIM KG (DE) 2001-02-20 US claimed
US-6191135-B1 Neurokinin antagonists BOEHRINGER INGELHEIM KG (DE) 2001-02-20 US disclosed
US-5985881-A TREATMENT AND PREVENTION OF RESPIRATORY DISORDERS, INFLAMMATORY EYE DISEASES, INFLAMMATORY SKIN DISEASES, INTESTINAL DISORDERS, OTHER INFLAMMATORY DISEASES BOEHRINGER INGELHEIM KG (DE) 1999-11-16 US disclosed